Literature DB >> 16012743

In silico characterization of LZTS3, a potential tumor suppressor.

Andreas Teufel1, Arndt Weinmann, Peter R Galle, Ansgar W Lohse.   

Abstract

Members of the leucine zipper tumor suppressor (LZTS) protein family are thought to play roles in cell growth modulation. The two currently known members were identified by analyzing genomic and chromosomal alterations reported to be either involved or deleted in various types of cancer, suggesting a causative relationship. By means of computational biology, we have now identified a novel member of the LZTS protein family named LZTS3. The corresponding gene was localized to chromosome 20p13 and consisted of three exons. The novel LZTS3 protein demonstrated a high similarity to LAPSER1/LZTS2 and FEZ1/LZTS1, two members of the LZTS family. The conserved FEZ1 domain contains a leucine zipper motif similar to the cAMP-responsive activating transcription factor 5. As FEZ1 inhibits cancer cell growth through the regulation of mitosis and its alteration resulted in abnormal cell growth, the LZTS3 protein was expected to have similar functions during cancer differentiation. Furthermore, the protein was conserved in vertebrates, as orthologs could be identified in mouse, rat, and zebrafish. The intracellular localization of the LZTS3 protein was predicted to be nuclear by means of Reinhardt's neural network and the k-nearest neighbor algorithm. An RT-PCR-based expression profile available from the human unidentified gene-encoded (HUGE) database demonstrated the highest expression in the brain and kidney, accompanied by lower expression in multiple other tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012743

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development.

Authors:  Yue Peng; Curtis Clark; Richard Luong; William H Tu; Jane Lee; Daniel T Johnson; Amrita Das; Thomas J Carroll; Zijie Sun
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

2.  Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.

Authors:  Daniel T Johnson; Richard Luong; Suk Hyung Lee; Yue Peng; Atossa Shaltouki; Jane T Lee; Dong Lin; Yuzhuo Wang; Zijie Sun
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

3.  LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin.

Authors:  Gregory Thyssen; Tzu-Huey Li; Lynn Lehmann; Ming Zhuo; Manju Sharma; Zijie Sun
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

4.  Fez1/Lzts1 a new mitotic regulator implicated in cancer development.

Authors:  Andrea Vecchione; Carlo M Croce; Gustavo Baldassarre
Journal:  Cell Div       Date:  2007-08-24       Impact factor: 5.130

5.  The oviductal transcriptome is influenced by a local ovarian effect in the sow.

Authors:  Rebeca López-Úbeda; Marta Muñoz; Luis Vieira; Ronald H F Hunter; Pilar Coy; Sebastian Canovas
Journal:  J Ovarian Res       Date:  2016-07-22       Impact factor: 4.234

Review 6.  Epigenetic changes in fibroblasts drive cancer metabolism and differentiation.

Authors:  Rajeev Mishra; Subhash Haldar; Surabhi Suchanti; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2019-12       Impact factor: 5.678

7.  Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.

Authors:  Xinkui Liu; Zhitong Bing; Jiarui Wu; Jingyuan Zhang; Wei Zhou; Mengwei Ni; Ziqi Meng; Shuyu Liu; Jinhui Tian; Xiaomeng Zhang; Yingfei Li; Shanshan Jia; Siyu Guo
Journal:  Med Sci Monit       Date:  2020-01-01

8.  Long non-coding RNA (lncRNA) PGM5P4-AS1 inhibits lung cancer progression by up-regulating leucine zipper tumor suppressor (LZTS3) through sponging microRNA miR-1275.

Authors:  Junpeng Feng; Jianhang Li; Peng Qie; Zhenhua Li; Yanzhao Xu; Ziqiang Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.